CD146: a potential therapeutic target for systemic sclerosis
نویسندگان
چکیده
منابع مشابه
Interleukin-6: a new therapeutic target in systemic sclerosis?
Interleukin-6 (IL-6) is a classic pro-inflammatory cytokine critical in mounting an effective immune response. It is secreted by a wide array of cell types; however, its effector cells are more restricted, owing to the fact that very few cells, except lymphocytes and hepatocytes, express the functional membrane IL-6 receptor thus reducing the number of IL-6-responsive cells. Trans-signalling, t...
متن کاملcxcr4: a potential chemokine receptor for future regenerative therapeutic target
understanding the molecular mechanisms in regeneration could help the stem cell therapists to improve the clinical practices and could be considered a major milestone in the translation of stem cell research to clinics. chemokines have been described as one of the most significant singling networks in stem cells homing and regeneration of damaged organs. cxcr4/cxcl12 has been known as a key pla...
متن کاملTherapeutic options for systemic sclerosis.
Systemic sclerosis is a uncommon connective tissue disorder characterized by vascular damage, immune cell activation and fibrogenesis. Each of these components may respond to different therapies. Therefore, a combination strategy treating all three processes is more likely to control the disease than single agent therapy. Clinical trials have gone a long way towards defining the therapy of scle...
متن کاملAnimal models of systemic sclerosis: insights into systemic sclerosis pathogenesis and potential therapeutic approaches.
PURPOSE OF REVIEW Animal models have been extremely valuable in contributing to a better understanding of the pathogenesis of systemic sclerosis. Discussed here are recent studies that have examined the molecular pathways and potential therapeutic approaches for systemic sclerosis using animal models. RECENT FINDINGS Reported evidence further indicates that the immune system plays a role in m...
متن کاملStatins and the vasculopathy of systemic sclerosis: potential therapeutic agents?
It has been postulated that endothelial cell injury is the initiating event in the pathogenesis of systemic sclerosis, causing attraction, attachment, migration and infiltration of activated T-cells and subsequent production of cytokines and growth factors. As a result of the action of these cytokines and growth factors, chemoattraction of fibroblasts into the vessel wall and transdifferentiati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Protein & Cell
سال: 2018
ISSN: 1674-800X,1674-8018
DOI: 10.1007/s13238-018-0531-x